©The Author(s) 2025.
World J Stem Cells. Oct 26, 2025; 17(10): 109369
Published online Oct 26, 2025. doi: 10.4252/wjsc.v17.i10.109369
Published online Oct 26, 2025. doi: 10.4252/wjsc.v17.i10.109369
Figure 8 Cartilage degeneration assessment after synovial mesenchymal stem cell-derived exosomes GrpE-like 1 delivery in rat osteoarthritis model.
A: Immunofluorescence analysis of collagen II, aggrecan, and matrix metalloproteinase-13 in rat cartilage tissue across experimental groups, visualizing key cartilage matrix and degradation markers; B-D: Quantitative fluorescence intensity analysis of collagen II (B), aggrecan (C) and matrix metalloproteinase-13 (D), revealing matrix protein preservation and potential cartilage regeneration. Scale bar: 50 μm. bP < 0.01 vs Control; dP < 0.01 vs OA; fP < 0.01 vs OA + Exo-oeNC; hP < 0.01 vs OA + Exo-shNC. MMP-13: Matrix metalloproteinase-13.
- Citation: Xiang CH, Zou L, Huang ZG, Zhang GJ, Zeng HL, He ZX, Dai ZS. Synovial mesenchymal stem cell-derived exosomes delivering GRPEL1 activate PINK1-mediated mitophagy to promote cartilage repair in arthritis. World J Stem Cells 2025; 17(10): 109369
- URL: https://www.wjgnet.com/1948-0210/full/v17/i10/109369.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v17.i10.109369